github link
Accession IconGSE54548

Common differentiating agents facilitate transcriptional reprogramming by bromodomain inhibition

Organism Icon Homo sapiens
Sample Icon 8 Downloadable Samples
Technology Badge Icon Affymetrix Human Human Exon 1.0 ST Array (huex10st)

Submitter Supplied Information

Description
Dimethyl sulfoxide (DMSO) and hexamethylene bisacetamide (HMBA) are biologically active molecules that have shown clinical efficacy in cancer and inflammation, though their therapeutic application has been limited, partly because their mechanism of action is unknown. We demonstrate that DMSO and HMBA facilitate rapid transcriptional reprogramming via competitive inhibition of bromodomain-containing proteins. These results identify novel therapeutic avenues and provide context to over 50 years of biomedical research with these agents.
PubMed ID
No associated PubMed ID
Publication Title
No associated publication
Total Samples
8
Submitter’s Institution
Authors
No associated authors

Samples

Show of 0 Total Samples
Filter
Add/Remove
Accession Code
Title
Cell line
Treatment
Time
Processing Information
Additional Metadata
No rows found
Loading...